D. Navaneetham

发表

Epitopes for human CD4+ cells on diphtheria toxin: Structural features of sequence segments forming epitopes recognized by most subjects

D. Mccormick, D. Okita, B. Diethelm-Okita, 1995, European journal of immunology.

Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet glycoprotein Ib alpha with thrombin anion-binding exosites I and II, respectively.

P. Walsh, F. Baglia, José A López, 2003, The Journal of biological chemistry.

Thrombin Activation of Factor XI on Activated Platelets Requires the Interaction of Factor XI and Platelet Glycoprotein Ibα with Thrombin Anion-binding Exosites I and II, Respectively*

P. Walsh, F. Baglia, José A López, 2003, Journal of Biological Chemistry.

Human Bronchial Epithelial and Endothelial Cells Express α7 Nicotinic Acetylcholine Receptors

E. Albuquerque, E. Pereira, A. Maus, 2001 .

Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors.

E. Albuquerque, R. Horton, E. Pereira, 1998, Molecular pharmacology.

T Cell Recognition of the Acetylcholine Receptor in Myasthenia Gravis a

Zeng-Yu Wang, P. Karachunski, D. Okita, 1998, Annals of the New York Academy of Sciences.

Mechanisms and specificity of factor XIa and trypsin inhibition by protease nexin 2 and basic pancreatic trypsin inhibitor.

D. Sinha, P. Walsh, D. Navaneetham, 2010, Journal of biochemistry.

Anti-Acetylcholine Receptor CD4+ T Cells in Myasthenia Gravis: Epitope repertoire and T cell receptor gene usage

Zeng-Yu Wang, J. Howard, B. Conti-Fine, 2000 .

P1 and P2' site mutations convert protease nexin-2 from a factor XIa inhibitor to a plasmin inhibitor.

Wenman Wu, D. Sinha, P. Walsh, 2013, Journal of biochemistry.

TCR vbeta usage of TSH receptor-specific CD4+ T cells in Graves' disease patients and healthy humans.

J. Morris, D. Mccormick, B. Conti-Fine, 1997, Journal of autoimmunity.

Structural and Mutational Analyses of the Molecular Interactions between the Catalytic Domain of Factor XIa and the Kunitz Protease Inhibitor Domain of Protease Nexin 2*

R. Babine, S. Abdel-Meguid, P. Walsh, 2005, Journal of Biological Chemistry.

Determinants of Affinity and Proteolytic Stability in Interactions of Kunitz Family Protease Inhibitors with Mesotrypsin*

D. Sinha, P. Walsh, Moh’d A. Salameh, 2010, The Journal of Biological Chemistry.

The Amyloid Precursor Protein/Protease Nexin 2 Kunitz Inhibitor Domain Is a Highly Specific Substrate of Mesotrypsin*

D. Sinha, P. Walsh, Moh’d A. Salameh, 2009, The Journal of Biological Chemistry.

Changes in binding of lectins to epididymal, ejaculated, and capacitated spermatozoa of the rhesus monkey

P. Sivashanmugam, M. Rajalakshmi, D. Navaneetham, 1996, The Anatomical record.

Organization for rare diseases India (ORDI) - addressing the challenges and opportunities for the Indian rare diseases' community.

V. Chandru, M. Hegde, K. Haldar, 2014, Genetics research.

Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity?

A. Maus, B. Conti-Fine, Sijin Lei, 2000, European journal of pharmacology.

Expression of the alpha 7 subunit of the nicotinic acetylcholine receptor in normal and myasthenic human thymuses.

J. Howard, A. Penn, B. Conti-Fine, 1997, Cellular and molecular biology.

Human thymuses express incomplete sets of muscle acetylcholine receptor subunit transcripts that seldom include the δ subunit

J. Howard, A. Penn, B. Conti-Fine, 2001, Muscle & nerve.

TCR-Vβ Usage in the Thymus and Blood of Myasthenia Gravis Patients☆

J. Howard, A. Penn, B. Conti-Fine, 1998 .

The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis.

Wenman Wu, P. Walsh, R. Tuma, 2012, Blood.

The Role of Factor XIa (FXIa) Catalytic Domain Exosite Residues in Substrate Catalysis and Inhibition by the Kunitz Protease Inhibitor Domain of Protease Nexin 2*

D. Sinha, P. Walsh, T. Miller, 2011, The Journal of Biological Chemistry.

Macromolecular substrate-binding exosites on both the heavy and light chains of factor XIa mediate the formation of the Michaelis complex required for factor IX-activation.

D. Sinha, P. Walsh, D. Navaneetham, 2007, Biochemistry.

The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis.

Wenman Wu, P. Walsh, R. Tuma, 2012, Blood.

TheAmyloidPrecursorProtein/ProteaseNexin2Kunitz InhibitorDomainIsaHighlySpecificSubstrateofMesotrypsin *

D. Sinha, P. Walsh, E. Radisky, 2010 .

The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis

D. Navaneetham, Z. Reichenbach, Wenman Wu, 2012 .

Organization for rare diseases India (ORDI) - addressing the challenges and opportunities for the Indian rare diseases' community.

V. Chandru, M. Hegde, K. Haldar, 2014, Genetics research.

Determinants of Affinity and Proteolytic Stability in Interactions of Kunitz Family Protease Inhibitors with Mesotrypsin*

D. Sinha, P. Walsh, Moh’d A. Salameh, 2010, The Journal of Biological Chemistry.